The Brief Dissociative Experiences Scale (DES-B) is an 8-item self-report questionnaire that measures how often an adult has experienced dissociative symptoms, such as feeling detached from the body or surroundings, over the past seven days. Modified for the DSM-5 field trials, it rates each experience on a 0 to 4 frequency scale and supports both screening and ongoing symptom monitoring.
Why healthcare providers use the DES-B
- Brief and low burden. Eight items take about two to four minutes to complete, so it fits easily into a busy intake or visit.
- Standardized severity. A consistent 0 to 4 rating gives you a repeatable measure of dissociative symptoms across patients and across visits.
- DSM-5 aligned. It was refined during the DSM-5 field trials as a measure of dissociation severity, giving it a recognized clinical basis.
- Sensitive to change. Repeated administration lets you track whether symptoms are improving or worsening over time.
Which settings use the DES-B?
- Outpatient mental health. Therapists and psychiatrists use it during assessment and ongoing care for trauma-related concerns.
- Trauma and PTSD programs. Clinicians screen for dissociation alongside post-traumatic stress symptoms.
- Integrated primary care. Behavioral health teams use it to flag dissociative symptoms that warrant closer assessment.
What does the DES-B measure?
The DES-B captures the frequency of common dissociative experiences over the past week. Rather than diagnosing a specific disorder, it quantifies how often symptoms occur so you can gauge severity and monitor change. Its items span several related domains:
- Depersonalization. Feeling detached from your own body, thoughts, or emotions.
- Derealization. Experiencing surroundings as unreal, dreamlike, or distant.
- Memory and awareness gaps. Losing track of time or finding evidence of actions you do not recall.
Scoring the DES-B
- Number of items: 8.
- Per-item scale: 0 (not at all) to 4 (more than once a day).
- Total score range: 0 to 32, summed across all eight items.
- Score direction: higher scores indicate more frequent, more severe dissociative symptoms.
The DES-B has no diagnostic cutoff. During the DSM-5 field trials, clinicians found an average score, the raw total divided by the number of items answered, reliable and clinically useful for rating overall severity on a 0 to 4 scale. If three or more items are unanswered, do not calculate a score. Interpret results alongside clinical interview and history, not in isolation. The bands below reflect that average-score severity rating.
| Average score | Interpretation | Suggested next step |
|---|---|---|
| 0 | None | Monitor |
| 1 | Mild | Monitor |
| 2 | Moderate | Consider further assessment |
| 3 | Severe | Consider further assessment |
| 4 | Extreme | Consider further assessment |
Best practices for administration
- Set a clear time frame. Remind patients that the items ask about the past seven days.
- Offer privacy. Dissociative symptoms can feel distressing to report, so give patients a private, unhurried setting.
- Use it repeatedly. Re-administer on a regular schedule, such as weekly, to track change rather than relying on a single score.
- Pair with clinical judgment. Use the score to guide conversation and clinical decision-making, not to replace assessment.
- Watch for missing items. If three or more items are skipped, do not calculate a total score.
How Zentake helps with the DES-B
- Automatic scoring. Zentake totals every DES-B on submit, so there is no hand-tallying.
- Longitudinal tracking. Re-send on a schedule and view change over time as symptoms shift.
- Before the visit. Patients complete the DES-B from home on any device, so results are ready before the visit for mental health practices.
- HIPAA compliant. Every response is encrypted, with a signed BAA available on every plan.
References
The DES-B was modified for the DSM-5 field trials by Constance Dalenberg and Eve Carlson, based on the Dissociative Experiences Scale. The American Psychiatric Association distributes it as a severity measure of dissociative symptoms for adults, which is also the source of the average-score severity guidance summarized above.
Last updated: August 2026